Lucid Diagnostics, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1287897,
    "name": "Lucid Diagnostics, Inc.",
    "stock_name": "Lucid Diagnostics, Inc.",
    "full_name": "Lucid Diagnostics, Inc.",
    "name_url": "stocks-analysis/lucid-diagnostics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.03",
    "chg": -0.03,
    "chgp": "-2.83%",
    "dir": -1,
    "prev_price": "1.06",
    "mcapval": "132.88",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US54948X1090",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.43 M",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lucid-diagnostics-inc-1287897-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Lucid Diagnostics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lucid-diagnostics-inc-technically-bullish-or-bearish-3548020",
        "imagepath": "",
        "date": "2025-09-20 20:08:01",
        "description": "As of 9 September 2025, the technical trend for Lucid Diagnostics, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. However, the daily moving averages are bearish, and the weekly KST is bearish, suggesting weakness in the short term. The Bollinger Bands show a mildly bearish stance on the weekly chart but mildly bullish on the monthly chart. The Dow Theory indicates no trend on the weekly timeframe but is mildly bullish on the monthly timeframe. \n\nIn terms of returns, Lucid Diagnostics has outperformed the S&P 500 over the past month (4.9% vs. 2.33%) and year-to-date (30.7% vs. 12.22%), but has significantly underperformed over the 3-year period (-42.16% vs. 70.41%). Overall, the current technical stance is mildly bearish, driven primarily by the bearish daily moving averages and the bearish..."
      },
      {
        "title": "Is Lucid Diagnostics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lucid-diagnostics-inc-overvalued-or-undervalued-3544202",
        "imagepath": "",
        "date": "2025-09-20 18:40:29",
        "description": "As of 13 November 2023, the valuation grade for Lucid Diagnostics, Inc. has moved from does not qualify to risky, indicating a shift in perceived risk associated with the investment. The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of -25.96, an EV to EBIT of -3.10, and an EV to EBITDA of -3.16, all of which suggest significant financial distress.\n\nIn comparison to its peers, Lucid Diagnostics is underperforming, with its EV to EBITDA ratio of -2.7185 being worse than Prenetics Global Ltd.'s -1.5438, while Pro-Dex, Inc. stands out with a very attractive P/E ratio of 14.7715. The company's recent stock performance shows a year-to-date return of 30.7%, which outpaces the S&P 500's 12.22%, but this is overshadowed by a three-year decline of -42.16% compared to the S&P's 70.41% gain, reinforcing the notion that the stock may not be a sound investment at i..."
      }
    ],
    "total": 6,
    "sid": "1287897",
    "stock_news_url": "https://www.marketsmojo.com/news/lucid-diagnostics-inc-1287897"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Lucid Diagnostics, Inc. technically bullish or bearish?

2025-09-20 20:08:01

As of 9 September 2025, the technical trend for Lucid Diagnostics, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. However, the daily moving averages are bearish, and the weekly KST is bearish, suggesting weakness in the short term. The Bollinger Bands show a mildly bearish stance on the weekly chart but mildly bullish on the monthly chart. The Dow Theory indicates no trend on the weekly timeframe but is mildly bullish on the monthly timeframe. In terms of returns, Lucid Diagnostics has outperformed the S&P 500 over the past month (4.9% vs. 2.33%) and year-to-date (30.7% vs. 12.22%), but has significantly underperformed over the 3-year period (-42.16% vs. 70.41%). Overall, the current technical stance is mildly bearish, driven primarily by the bearish daily moving averages and the bearish...

Is Lucid Diagnostics, Inc. overvalued or undervalued?

2025-09-20 18:40:29

As of 13 November 2023, the valuation grade for Lucid Diagnostics, Inc. has moved from does not qualify to risky, indicating a shift in perceived risk associated with the investment. The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of -25.96, an EV to EBIT of -3.10, and an EV to EBITDA of -3.16, all of which suggest significant financial distress. In comparison to its peers, Lucid Diagnostics is underperforming, with its EV to EBITDA ratio of -2.7185 being worse than Prenetics Global Ltd.'s -1.5438, while Pro-Dex, Inc. stands out with a very attractive P/E ratio of 14.7715. The company's recent stock performance shows a year-to-date return of 30.7%, which outpaces the S&P 500's 12.22%, but this is overshadowed by a three-year decline of -42.16% compared to the S&P's 70.41% gain, reinforcing the notion that the stock may not be a sound investment at i...

View All News